BIAS
ORIC icon

Beacon Investment Advisory Services’s Oric Pharmaceuticals ORIC Stock Holding History

Beacon Investment Advisory Services’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$88.3K – 287
2022
Q4 		$88.3K Hold
15,000
– – ﹤0.01% 276
2022
Q3 		$48K Hold
15,000
– – ﹤0.01% 273
2022
Q2 		$67K Hold
15,000
– – ﹤0.01% 281
2022
Q1 		$80K Hold
15,000
– – ﹤0.01% 296
2021
Q4 		$221K Sell
15,000
-2,556
-15% -$39.9K 0.01% 292
2021
Q3 		$367K Hold
17,556
– – 0.02% 233
2021
Q2 		$311K Hold
17,556
– – 0.01% 257
2021
Q1 		$430K Hold
17,556
– – 0.02% 213
2020
Q4 		$594K Buy
+17,556
New +$504K 0.03% 173

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return